BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38401376)

  • 1. Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers.
    Hakami ZH
    Pathol Res Pract; 2024 Mar; 255():155216. PubMed ID: 38401376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
    Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
    Vedeld HM; Goel A; Lind GE
    Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquaporins: Their role in gastrointestinal malignancies.
    Nagaraju GP; Basha R; Rajitha B; Alese OB; Alam A; Pattnaik S; El-Rayes B
    Cancer Lett; 2016 Apr; 373(1):12-18. PubMed ID: 26780474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. piRNA: A promising biomarker in early detection of gastrointestinal cancer.
    Ameli Mojarad M; Ameli Mojarad M; Shojaee B; Nazemalhosseini-Mojarad E
    Pathol Res Pract; 2022 Feb; 230():153757. PubMed ID: 34998210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers.
    Song G; Wang L; Tang J; Li H; Pang S; Li Y; Liu L; Hu J
    Metabolomics; 2023 Apr; 19(4):36. PubMed ID: 37014438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
    Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
    Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies.
    Wang Y; Li Z; Xu S; Guo J
    J Clin Lab Anal; 2020 Jul; 34(7):e23359. PubMed ID: 32419229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
    Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
    Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers.
    Li Y; Sui S; Goel A
    Semin Cancer Biol; 2024 Feb; 99():5-23. PubMed ID: 38341121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Biomarkers for the Early Diagnosis of Gastrointestinal Cancers.
    Nellore J; Narayan AS; Sunkar S; Nachiyar CV; Jayakrishna T; Peela S
    Crit Rev Oncog; 2020; 25(4):335-354. PubMed ID: 33639061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.
    Gheytanchi E; Madjd Z; Janani L; Rasti A; Ghods R; Atyabi F; Asadi-Lari MH; Babashah S
    Syst Rev; 2017 Nov; 6(1):228. PubMed ID: 29149908
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Li L; Li M; Jiang Z; Wang X
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HnRNP Family as Prognostic Biomarkers in Five Major Types of Gastrointestinal Cancer.
    Chen X; Gong R; Wang J; Ma B; Lei K; Ren H; Wang J; Zhao C; Wang L; Yu Q
    Curr Gene Ther; 2022; 22(5):449-461. PubMed ID: 35794744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel.
    Goel A
    Future Oncol; 2017 Dec; 13(28):2511-2514. PubMed ID: 29168653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies.
    Adamopoulos PG; Tsiakanikas P; Scorilas A
    Biol Chem; 2018 Jul; 399(8):821-836. PubMed ID: 29883317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers.
    Pourhanifeh MH; Vosough M; Mahjoubin-Tehran M; Hashemipour M; Nejati M; Abbasi-Kolli M; Sahebkar A; Mirzaei H
    Pharmacol Res; 2020 Nov; 161():105133. PubMed ID: 32822869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
    Grady WM; Yu M; Markowitz SD
    Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
    Flickinger JC; Rappaport JA; Barton JR; Baybutt TR; Pattison AM; Snook AE; Waldman SA
    Biomark Med; 2021 Feb; 15(3):201-217. PubMed ID: 33470843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.